Blood Cancer Treatment
India’s First Indigenous CAR-T Cell Therapy NexCAR19 Brings Hope to Blood Cancer Patients, But Awareness Deficit Remains
NexCAR19, India's first approved CAR-T cell therapy developed by IIT Bombay and Tata Memorial Centre, offers affordable indigenous treatment for relapsed blood cancer patients. However, low awareness and delayed referrals remain key challenges for eligible families.
